THE COMPARATIVE EFFICACY OF TELAPREVIR VERSUS BOCEPREVIR IN TREATMENT-NAIVE AND TREATMENT-EXPERIENCED PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS

被引：2
|
作者：
Diels, J. [1 ]
Cure, S. [2 ]
Gavart, S. [3 ]
机构：
[1] Janssen Pharmaceut NV, Janssen EMEA Hlth Econ & Market Access, Beerse, Belgium
[2] I3 Innovus, Uxbridge, Middx, England
[3] Janssen Pharmaceut NV, Worldwide Market Access, Janssen Global Serv, Beerse, Belgium
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 07期
关键词：
D O I：
10.1016/j.jval.2011.08.195
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A266 / A266
页数：1
相关论文
共 50 条
  • [31] ESTIMATING THE COST-EFFECTIVENESS OF DACLATASVIR PLUS SOFOSBUVIR IN TREATMENT-NAIVE, TREATMENT-EXPERIENCED AND INTERFERON-INELIGIBLE/INTOLERANT PATIENTS WITH ADVANCED CHRONIC HEPATITIS C GENOTYPE 1 INFECTION
    McEwan, P.
    Webster, S.
    Ward, T.
    Kalsekar, A.
    Yuan, Y.
    Brenner, M.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S627 - S628
  • [32] CHARACTERIZATION OF THE EARLY VIRAL KINETICS IN COMPENSATED CIRRHOTIC TREATMENT-EXPERIENCED PATIENTS TREATED WITH BOCEPREVIR AND TELAPREVIR
    Laouenan, C.
    Guedj, J.
    Lapalus, M.
    Khelifa-Mouri, F.
    Martinot-Peignoux, M.
    Boyer, N.
    Serfaty, L.
    Bronowicki, J. -P.
    Zoulim, F.
    Mentre, F.
    Marcellin, P.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S347 - S347
  • [33] Health-related quality of life in genotype 1 treatment-naive chronic hepatitis C patients receiving telaprevir combination treatment in the ADVANCE study
    Vera-Llonch, M.
    Martin, M.
    Aggarwal, J.
    Donepudi, M.
    Bayliss, M.
    Goss, T.
    Younossi, Z.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 38 (02) : 124 - 133
  • [34] Treatment of chronic HCV genotype 1 infection with telaprevir: a Bayesian mixed treatment comparison of fixed-length and response-guided treatment regimens in treatment-naive and -experienced patients
    Goralczyk, Armin D.
    Cameron, Silke
    Amanzada, Ahmad
    BMC GASTROENTEROLOGY, 2013, 13
  • [35] EARLY VIROLOGICAL RESPONSE PROFILES WITH TELAPREVIR (T) IN COMBINATION WITH PEGINTERFERON-ALFA-2A (P) AND RIBAVIRIN (R) IN GENOTYPE 1 HCV TREATMENT-NAIVE AND TREATMENT-EXPERIENCED PATIENTS ARE SIMILAR
    Poordad, F.
    McHutchison, J. G.
    Shiffman, M. L.
    Berg, T.
    Muir, A. J.
    Manns, M. P.
    Di Bisceglie, A. M.
    Terrault, N.
    Picchio, G.
    Kwong, A.
    Bengtsson, L.
    George, S.
    Adda, N.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S121 - S122
  • [36] Efficacy of hepatic arterial infusion chemotherapy between treatment-naive and treatment-experienced patients with advanced hepatocellular carcinoma
    Yu, Hyung-Min
    Kim, Seung-Hun
    Myung, Eun
    Myung, Dea-Seong
    Cho, Sung-Bum
    Lee, Wan-Sik
    Joo, Young-Eun
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 423 - 423
  • [37] Optimizing management of treatment-naive and treatment-experienced HIV+ patients: the role of maraviroc
    Poveda, Eva
    Soriano, Vincent
    HIV AIDS-RESEARCH AND PALLIATIVE CARE, 2010, 2 : 51 - 58
  • [38] Exposure-Response Relationships in Telaprevir Combination Therapy in Treatment-NaiVE Genotype 1 Chronic HCV Patients
    Gordon, Stuart C.
    Muir, Andrew J.
    Garg, Varun
    Henshaw, Joshua W.
    GASTROENTEROLOGY, 2012, 142 (05) : S931 - S931
  • [39] Cost-Effectiveness of Dolutegravir in HIV-1 Treatment-Naive and Treatment-Experienced Patients in Canada
    Despiégel N.
    Anger D.
    Martin M.
    Monga N.
    Cui Q.
    Rocchi A.
    Pulgar S.
    Gilchrist K.
    Refoios Camejo R.
    Infectious Diseases and Therapy, 2015, 4 (3) : 337 - 353
  • [40] Treatment of chronic hepatitis C in treatment-naive patients
    Ferreira, Marcelo Simao
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2007, 11 : 45 - 49
12345